AestheticsFeatured Articles

What are the Skincare Benefits of Niacinamide?

By September 28, 2020No Comments

Featured Article

Featured Article

A 2016 study from Journal of Drugs in Dermatology suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read more

A 2016 study from Journal of Drugs in Dermatology (“Efficacy and Tolerability of a Skin Brightening/Anti-Aging Cosmeceutical Containing Retinol 0.5%, Niacinamide, Hexylresorcinol, and Resveratrol“), which was recently cited in an article on Prevention.com, suggests that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection. 

Patricia Farris MD, Joshua Zeichner MD, and Diane Berson MD

 

Consumers are increasingly interested in over-the-counter skin care products that can improve the appearance of photodamaged and aging skin. This 10-week, open-label, single- center study enrolled 25 subjects with mild to moderate hyperpigmentation and other clinical stigmata of cutaneous aging including fine lines, sallowness, lack of clarity, and wrinkling. Their mean age was 53.4±7.7 years. The test product contained retinol 0.5% in combination with niacinamide 4.4%, resveratrol 1%, and hexylresorcinol 1.1% in a moisturizing base. Subjects were provided a skin care regimen including a cleanser, hydrating serum, moisturizer, and an SPF 30 sunscreen for daily use. The test product was applied only at night.

The use of this skin brightening/anti-aging cosmeceutical was found to provide statistically significant improvements in all efficacy endpoints by study end. Fine lines, radiance, and smoothness were significantly improved as early as week 2 (P<.001). By week 4, hyperpigmentation, overall skin clarity, evenness of skin tone, and wrinkles showed statistically significant improvement compared to baseline. Mild retinoid dermatitis including flaking and redness occurred early in the study as reflected by tolerability scores. By week 10, subjects reported no stinging, itching, dryness, or tingling.

The results of this open-label clinical study suggest that a topical cream containing retinol 0.5% in combination with niacinamide, resveratrol, and hexylresorcinol is efficacious and tolerable for skin brightening/anti-aging when used with a complementary skin care regimen including SPF 30 sun protection.

Read Full Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD featuring Author Spotlight: Aaron S. Farberg MD FAAD

Author Spotlight: Aaron S. Farberg MD FAAD

| Author Spotlight, Featured Articles, Latest News, Medical Derm | No Comments
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Aaron S. Farberg MD FAAD, one of the co-authors of “Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists:…
Journal of Drugs in Dermatology JDD Article about A Systematic Evaluation of Monkeypox Public Health Educational Resources

A Systematic Evaluation of Mpox Public Health Educational Resources

| Featured Articles, Global Health, Latest News | No Comments
Public health messaging misses the mark on Monkeypox and HIV A cross‑jurisdiction survey of publicly available Monkeypox and HIV materials from state, large metropolitan and select non‑metro U.S. health departments…
Journal of Drugs in Dermatology JDD Article about Excimer Laser for Plaque Psoriasis: A Systematic Review and Meta-analysis

Celebrating a Decade of Conversation: Dr. Adam Friedman and the JDD Podcast

| Featured Articles, Lasers & Light Devices, Latest News | No Comments
Ten Years, One Live Celebration: Join the conversation We were proud to celebrate a remarkable milestone at ODAC 2026, held January 16-19, 2026. It was a fitting place to honor…

Leave a Reply